Approval for the addition of a catheter revision kit for use with the subject system. the device, as modified, will be marketed under the trade name prometra programmable implantable pump system and is indicated for intrathecal infusion of infumorph (preservative-free morphine sulfate) or preservative-free sterile 0.9% saline solution (sodium chloride injection, usp).